Ross Kayuha CEO
30+ years’ executive experience with successful IPO and acquisition.
Ronald Bracken COO
28 years’ of experience in medical device design and R&D. Most recently served as VP of R&D and Special Initiatives at C.R. Bard, including the development and launch of anti-infective medical devices.
Dr. Jed Johnson CTO
PhD in Materials Science and Engineering, and is a recognized expert on synthetic scaffolds for Tissue Engineering.
Chris Breuer MD
Co-Director of the Tissue Engineering Program at Nationwide Children’s Hospital and Director of Tissue Engineering in The Ohio State University Wexner Medical Center’s Center for Regenerative Medicine and Cell Based Therapies.
Narutoshi Hibino MD/PhD
Assistant Professor of Surgery for Johns Hopkins Hospital.Dr. Hibino has 15 years of subspecialty training in cardiac surgery that includes fellowships in both adult and pediatric cardiac surgery.